地理加权回归量化T2-FLAIR错配征并预测低级别胶质瘤分子状态
本研究基于108例术前低级别胶质瘤的多参数MRI,采用地理加权回归量化T2-FLAIR错配征并构建残差签名,用于预测IDH突变和1p/19q非共缺失状态。结果显示该签名在预测分子状态时AUC达0.98,预测错配征AUC为0.93,提示其可作为视觉评估的客观补充。
要点
- T2-FLAIR错配征是IDH突变且1p/19q非共缺失胶质瘤的影像标志,视觉评估阳性预测值高。
- 地理加权回归残差签名可客观量化错配征,预测分子状态AUC 0.98。
- 该量化方法预测错配征本身AUC 0.93,有望辅助报告标准化。
关键影像表现/征象
- T2-FLAIR错配征表现为T2高信号而FLAIR相应区域信号被抑制,原文将其作为IDH突变且1p/19q非共缺失胶质瘤的影像标志。
- 原文未报告具体信号强度阈值或视觉分级标准。
诊断标准与关键数值
- 分类器预测IDH突变且1p/19q非共缺失的AUC为0.98,并报告高特异度和敏感度(原文未给出具体数值)。
- 分类器预测T2-FLAIR错配征的AUC为0.93。
临床应用与阅片要点
- 阅片时可关注T2高信号与FLAIR信号抑制不匹配的区域,作为提示IDH突变和1p/19q非共缺失的线索。
- 量化残差签名可作为视觉判读的辅助工具,但原文未提供可直接用于报告的阈值。
局限性
- 回顾性研究,样本来自单一公开数据库。
- 原文指出需前瞻性多中心研究验证该量化方法的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The T2-FLAIR mismatch sign is a validated imaging sign of isocitrate dehydrogenase-mutant 1p/19q noncodeleted gliomas. It is identified by radiologists through visual inspection of preoperative MR imaging scans and has been shown to identify isocitrate dehydrogenase-mutant 1p/19q noncodeleted gliomas with a high positive predictive value. We have developed an approach to quantify the T2-FLAIR mismatch signature and use it to predict the molecular status of lower-grade gliomas.
MATERIALS AND METHODS: We used multiparametric MR imaging scans and segmentation labels of 108 preoperative lower-grade glioma tumors from The Cancer Imaging Archive. Clinical information and T2-FLAIR mismatch sign labels were obtained from supplementary material of relevant publications. We adopted an objective analytic approach to estimate this sign through a geographically weighted regression and used the residuals for each case to construct a probability density function (serving as a residual signature). These functions were then analyzed using an appropriate statistical framework.
RESULTS: We observed statistically significant (P value = .05) differences between the averages of residual signatures for an isocitrate dehydrogenase-mutant 1p/19q noncodeleted class of tumors versus other categories. Our classifier predicts these cases with area under the curve of 0.98 and high specificity and sensitivity. It also predicts the T2-FLAIR mismatch sign within these cases with an under the curve of 0.93.
CONCLUSIONS: On the basis of this retrospective study, we show that geographically weighted regression-based residual signatures are highly informative of the T2-FLAIR mismatch sign and can identify isocitrate dehydrogenase-mutation and 1p/19q codeletion status with high predictive power. The utility of the proposed quantification of the T2-FLAIR mismatch sign can be potentially validated through a prospective multi-institutional study.
引用
- Mohammed, Ravikumar, Warner, et al. Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas. AJNR Am J Neuroradiol. 2021. PMID: 34764084. doi:10.3174/ajnr.A7341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。